ESMO Advanced Course on Early Drug Development 2026: Istanbul

To foster, educate and mentor the next generation of Phase I/Early Drug Development Programmes in oncology centres from both the established and emerging economies in the Middle-East and European region. To understand the fundamentals of establishing and running a successful Phase I/Early Drug Development Programme: from an in-depth understanding of trial selection to patient coordination, running a programme, effectively engaging with sponsors and fellow PIs, regional and international engagement, regulatory processes. To bridge the gap between the key stakeholders in the drug development process in the Middle-East region: investigators, sponsors (Pharma and Biotech), Contract Research Organization (CRO), and regulatory bodies